Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep-Oct;28(5):516-521.
doi: 10.4103/jisp.jisp_565_23. Epub 2025 Feb 26.

Effect of exposure to the carcinogen 50 ppm 4-nitroquinoline 1-oxide on alveolar bone loss

Affiliations

Effect of exposure to the carcinogen 50 ppm 4-nitroquinoline 1-oxide on alveolar bone loss

Marcelo Ekman Ribas et al. J Indian Soc Periodontol. 2024 Sep-Oct.

Abstract

Background: The objective of this study was to analyze the effect of exposure to the carcinogen 4-nitroquinoline 1-oxide (4NQO), with or without experimental periodontitis (EP), on alveolar bone loss (ABL) in rats.

Materials and methods: Male Wistar rats (n = 84) were divided into Group 1: no EP and no exposure to 4NQO; Group 2: exposure to 4NQO (50 ppm) only; Group 3: EP only; and Group 4: after 20 weeks of exposure to 4NQO (50 ppm), EP was induced by placing a silk ligature on the upper right maxillary second molar for 15 days. Macroscopic analysis of the tongue and morphometric analysis of ABL were performed. Kruskal-Wallis and Mann-Whitney U tests were used, and a significance level of P < 0.05 was adopted.

Results: All animals exposed to 4NQO presented macroscopic lesions on the tongue. When considering the side with EP, no statistically significant difference was demonstrated between Groups 3 (median: 0.76; intervals interquartile [IQ]: 0.42-0.45) and 4 (median: 0.78; IQ: 0.70-0.80). In the side without EP, Group 4 (median: 0.51 mm; IQ: 0.45-0.70) presented significantly higher ABL compared to Group 1 (median: 0.41 mm; IQ: 0.38-0.43). Group 3 (median: 0.44; IQ: 0.41-0.47) showed no significant difference when compared to Groups 1 (median: 0.41; IQ: 0.38-0.43) and 2 (median: 0.46; IQ: 0.41-0.54).

Conclusions: It was concluded that higher ABL occurred in the presence of a carcinogen. However, the combination of both 4NQO and EP did not promote higher ABL.

Keywords: Inflammation; mouth neoplasms; periodontal diseases; rats.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
A flowchart illustrating the different experimental phases of the study. 4NQO – 4-nitroquinoline 1-oxide
Figure 2
Figure 2
An example of the five measurements conducted for assessing alveolar bone loss in the present study
Figure 3
Figure 3
Macroscopic view of the tongue from an animal not exposed to a carcinogen (a), an animal exposed to 4-nitroquinoline 1-oxide (4NQO) with a less pronounced lesion (b), and an animal exposed to 4NQO with a well-differentiated lesion (c). Histopathological analyses were performed in the tongue and categorized into no alteration, hyperplasia, mild dysplasia, moderate dysplasia, severe dysplasia, carcinoma in situ, well-differentiated carcinoma, moderately differentiated carcinoma, and poorly differentiated carcinoma
Figure 4
Figure 4
Boxplot of alveolar bone loss (in millimeters) on the side without (a) and with experimental periodontitis (EP) (b). Group 1 (control) indicates no EP and no exposure to 4-nitroquinoline 1-oxide (4NQO). Group 2 (4NQO) indicates exposure to 4NQO without EP. Group 3 (EP) indicates EP without exposure to 4NQO. Group 4 (4NQO+EP) indicates 20 weeks of exposure to 4NQO with EP induced for 15 days. *Statistical significance (P < 0.05)

References

    1. Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2014;64:57–80. - PMC - PubMed
    1. Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of severe periodontitis in 1990-2010: A systematic review and meta-regression. J Dent Res. 2014;93:1045–53. - PMC - PubMed
    1. Beck JD, Papapanou PN, Philips KH, Offenbacher S. Periodontal medicine: 100 Years of progress. J Dent Res. 2019;98:1053–62. - PubMed
    1. Tezal M, Sullivan MA, Reid ME, Marshall JR, Hyland A, Loree T, et al. Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg. 2007;133:450–4. - PubMed
    1. Vered M, Dayan D. Tongue cancer: An ongoing problem which needs new therapeutic approaches. Harefuah. 2013;152:352–5. 368, 367. - PubMed

LinkOut - more resources